|
⚲
|
| Keyboard |
| Stacey Jennifer Evans
✚
|
|
|---|---|
| CIK # | 0001321326 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001321326] | |
| 4 | [0001321326] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Context Therapeutics Inc | |
| Stacey Jennifer Evans | |
| Neogen Corp | |
| Galera Therapeutics Inc | |
| Antares Pharma Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Context Therapeutics Inc CNTX
Stock Option (right to buy) · derivative
|
2025-06-12 | Grant | 123,500 | $0.00 | |
|
Context Therapeutics Inc CNTX
Stock Option (right to buy) · derivative
|
2024-06-13 | Grant | 25,000 | $0.00 | |
|
Context Therapeutics Inc CNTX
Stock Option (right to buy) · derivative
|
2023-05-31 | Grant | 25,000 | $0.00 | |
|
Galera Therapeutics Inc GRTX
Stock Option (Right to Buy) · derivative
|
2023-02-25 | Grant | 135,000 | $0.00 | |
|
Context Therapeutics Inc CNTX
Stock Option (right to buy) · derivative
|
2022-06-02 | Grant | 25,000 | $0.00 | |
|
Galera Therapeutics Inc GRTX
Stock Option (Right to Buy) · derivative
|
2022-02-28 | Grant | 75,000 | $0.00 | |
|
Galera Therapeutics Inc GRTX
Stock Option (Right to Buy) · derivative
|
2021-10-08 | Grant | 130,000 | $0.00 | |
|
Antares Pharma Inc ATRS
Common Stock
|
2015-05-28 | Grant | 70,239 | $0.00 | |
|
Antares Pharma Inc ATRS
Common Stock
|
2015-05-28 | Tax withheld | 2,469 | $2.18 | 5,382 |
|
Antares Pharma Inc ATRS
Stock option (right to buy) · derivative
|
2015-05-28 | Grant | 142,550 | $0.00 | |
|
Antares Pharma Inc ATRS
Stock option (right to buy) · derivative
|
2015-03-10 | Grant | 47,000 | $0.00 | |
|
Antares Pharma Inc ATRS
Stock option (right to buy) · derivative
|
2014-05-29 | Grant | 100,000 | ||
|
Antares Pharma Inc ATRS
Common Stock
|
2014-05-29 | Grant | 24,272 | ||
|
Antares Pharma Inc ATRS
Common Stock
|
2014-05-29 | Grant | 48,544 |